ACE2 and COVID-19: The application of mouse models to investigate COVID-19 pathogenesis has been hindered by the fact that the wild-type SARS-CoV-2 spike protein is unable to bind the mouse ACE2 protein, a necessary first step in viral cellular entry and infection [1,2].